Learning Collaborative Call to Discuss Infant RSV

AIM, in collaboration with the CDC, hosts a Learning Collaborative to increase the capacity to equitably protect infants from serious illness and death due to RSV. Join us for a new session of the Birthing Hospitals and VFC: A Learning Collaborative to Protect Infants from RSV, on Thursday, November 13, at 2 pm ET.

This session features AIM Chief Medical Officer Michelle Fiscus, MD, FAAP, who will discuss the 2024-2025 season data and review available vaccines and long-acting monoclonal antibody products for mothers and infants. California Department of Health Vaccines for Children Program Coordinator Claudia Aguiluz will discuss the allocation process they developed with their birthing institutions for dose allocation in the 2025-2026 RSV season.